Canine (Canis lupus familiaris) Research Reagents

Anticuerpos y proteínas recombinantes Canine (Canis lupus familiaris) — reactivos validados por especie para investigación. abinScience.

Por qué los investigadores eligen abinScience

Validación específica por especie Antibodies validated with confirmed reactivity to your model organism using appropriate positive controls.

Amplia cobertura de dianas Immune markers, signaling molecules, structural proteins, and disease-relevant biomarkers.

Datos de reactividad cruzada Detailed species cross-reactivity information provided on every product datasheet.

Múltiples aplicaciones Validated for WB, IHC, IF, ELISA, and FC across veterinary, developmental, and comparative biology research.

Fabricante original In-house production with rigorous quality control — reliable supply and consistent quality.

Documentos & datos de QC

Download product datasheets, imágenes de validación (WB/IHC/IF/FC), CoA, and application protocols on each product page. All data is lot-specific.

Preguntas frecuentes

¿Cómo se validan sus anticuerpos?

Every antibody is validated in its listed applications (WB, IHC, IF, ELISA, FC) with supporting images and data on the product page. We use positive and negative controls plus knockout/knockdown verification where available.

¿Ofrecen anticuerpos conjugados?

Yes — HRP, AP, biotin, FITC, PE, APC, Alexa Fluor, and other fluorochrome conjugates are available. Custom conjugation services are also offered for bulk orders.

¿Con qué especies reaccionan sus anticuerpos?

Most antibodies target human, mouse, and rat. Many show validated cross-reactivity with additional species. Check the product datasheet for confirmed reactivity data.

¿Cuál es su política de reemplazo?

If a product does not perform as described under recommended conditions, contact us within 30 days for replacement or credit. Our technical team will help troubleshoot first.

¿Puedo obtener anticuerpos personalizados?

Yes — our parent company AtaGenix offers full custom antibody development from immunogen design through hybridoma screening and scale-up production.